Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis
Acta Neuropathologica · 2024
DOI: 10.1007/s00401-024-02794-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Mónica Zufiría und 34 weiteren Autor:innen. Beteiligte Einrichtung: Neurosciences Area, Biogipuzkoa Health Research Institute, 20014, Donostia/San Sebastian, Spain. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Muscle, Skeletal, Forkhead Box Protein O1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Diputación Foral de Gipuzkoa.
Abstract (Originalsprache)
Amyotrophic Lateral Sclerosis (ALS) is a multisystemic neurodegenerative disorder, with accumulating evidence indicating metabolic disruptions in the skeletal muscle preceding disease symptoms, rather than them manifesting as a secondary consequence of motor neuron (MN) degeneration. Hence, energy homeostasis is deeply implicated in the complex physiopathology of ALS and skeletal muscle has emerged as a key therapeutic target. Here, we describe intrinsic abnormalities in ALS skeletal muscle, both in patient-derived muscle cells and in muscle cell lines with genetic knockdown of genes related to familial ALS, such as TARDBP (TDP-43) and FUS . We found a functional impairment of myogenesis that parallels defects of glucose oxidation in ALS muscle cells. We identified FOXO1 transcription factor as a key mediator of these metabolic and functional features in ALS muscle, via gene expression profiling and biochemical surveys in TDP-43 and FUS-silenced muscle progenitors. Strikingly, inhibition of FOXO1 mitigated the impaired myogenesis in both the genetically modified and the primary ALS myoblasts. In addition, specific in vivo conditional knockdown of TDP-43 or FUS orthologs ( TBPH or caz ) in Drosophila muscle precursor cells resulted in decreased innervation and profound dysfunction of motor nerve terminals and neuromuscular synapses, accompanied by motor abnormalities and reduced lifespan. Remarkably, these phenotypes were partially corrected by foxo inhibition, bolstering the potential pharmacological management of muscle intrinsic abnormalities associated with ALS. The findings demonstrate an intrinsic muscle dysfunction in ALS, which can be modulated by targeting FOXO factors, paving the way for novel therapeutic approaches that focus on the skeletal muscle as complementary target tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurosciences Area, Biogipuzkoa Health Research Institute, 20014, Donostia/San Sebastian, Spain.
- CIBERNED, ISCIII (CIBER, Carlos III Institute, Spanish Ministry of Sciences and Innovation), 28031, Madrid, Spain.
- Stem Cells and Aging Group, Biogipuzkoa Health Research Institute, 20014, Donostia/San Sebastian, Spain.
- Department of Neurology, Donostialdea Integrated Health Organization, Osakidetza Basque Health Service, 20014, Donostia/San Sebastian, Spain.
- Department of Pediatrics, Faculty of Medicine and Nursery, University of the Basque Country UPV/EHU, 20014, Donostia/San Sebastian, Spain.
- Cell Culture Platform, Biodonostia Health Research Institute, 20014, Donostia/San Sebastian, Spain.
ORCID-Profile: Mónica Zufiría, Oihane Pikatza-Menoio, Maddi Garciandia-Arcelus, Xabier Bengoetxea, Andrés Jiménez, Amaia Elicegui, María Levchuk, Olatz Arnold-García, Jon Ondaro, Pablo Iruzubieta, Laura Rodríguez-Gómez, Uxoa Fernández-Pelayo, Mikel Muñoz-Oreja, Ana Aiastui, José Manuel García-Verdugo, Vicente Herranz-Pérez, Miren Zulaica, Juan José Poza, Rebeca Ruiz-Onandi, Roberto Fernández-Torrón, Mario Bonilla, Ana Lersundi, Gorka Fernández-Eulate, Javier Riancho, Ainara Vallejo-Illarramendi, Ian James Holt, Amets Sáenz, Edoardo Malfatti, Stéphanie Duguez, Lorea Blázquez, Adolfo López de Munain, Gorka Gerenu, Francisco Gil-Bea, Sonia Alonso-Martín
Förderung
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Instituto de Salud Carlos III
- Diputación Foral de Gipuzkoa
- EiTB Maratoia
- Osasun Saila, Eusko Jaurlaritzako
- Hezkuntza, Hizkuntza Politika Eta Kultura Saila, Eusko Jaurlaritza
- Euskal Herriko Unibertsitatea
- Spanish National Plan for Scientific and Technical Research and Innovation
Zitieren
APA
Zufiría, M., Pikatza-Menoio, O., Garciandia-Arcelus, M., Bengoetxea, X., Jiménez, A., Elicegui, A., Levchuk, M., Arnold-García, O., Ondaro, J., Iruzubieta, P., Rodríguez-Gómez, L., Fernández-Pelayo, U., Muñoz-Oreja, M., Aiastui, A., García-Verdugo, J. M., Herranz-Pérez, V., Zulaica, M., Poza, J. J., Ruiz-Onandi, R., …, & Alonso-Martín, S. (2024). Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02794-y
Vancouver
Zufiría M, Pikatza-Menoio O, Garciandia-Arcelus M, Bengoetxea X, Jiménez A, Elicegui A, et al. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02794-y
BibTeX
@article{Zufira2024,
author = {Zufiría, Mónica and Pikatza-Menoio, Oihane and Garciandia-Arcelus, Maddi and Bengoetxea, Xabier and Jiménez, Andrés and Elicegui, Amaia and Levchuk, María and Arnold-García, Olatz and Ondaro, Jon and Iruzubieta, Pablo and Rodríguez-Gómez, Laura and Fernández-Pelayo, Uxoa and Muñoz-Oreja, Mikel and Aiastui, Ana and García-Verdugo, José Manuel and Herranz-Pérez, Vicente and Zulaica, Miren and Poza, Juan José and Ruiz-Onandi, Rebeca and Fernández-Torrón, Roberto and Espinal, Juan Bautista and Bonilla, Mario and Lersundi, Ana and Fernández-Eulate, Gorka and Riancho, Javier and Vallejo-Illarramendi, Ainara and Holt, Ian James and Sáenz, Amets and Malfatti, Edoardo and Duguez, Stéphanie and Blázquez, Lorea and López de Munain, Adolfo and Gerenu, Gorka and Gil-Bea, Francisco and Alonso-Martín, Sonia},
title = {Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis},
journal = {Acta Neuropathologica},
year = {2024},
doi = {10.1007/s00401-024-02794-y}
}
EUVIMED